FDA approves new drug to treat Alzheimer’s disease

July 2, 2024

A new drug to treat Alzheimer’s disease was approved by the U.S. Food and Drug Administration on Tuesday.

New moms advised to do two hours of moderate to vigorous exercise a week
New moms should be strongly encouraged to begin clocking up at least two hours of moderate to vigorous intensity physical activity such as brisk walking and muscle-strengthening exercises each week in the first three months after birth, when physically able, to improve health and well-being, say experts in a new guideline published by the British Journal of Sports Medicine.
Open-label placebo appears to reduce premenstrual symptoms, study suggests
Women affected by premenstrual syndrome (PMS) appear to experience less intense and debilitating symptoms after taking placebo pills even when told they do not contain any active medication, suggests a study published in the open-access journal BMJ Evidence-Based Medicine.
Q&A: Canada slowest in reporting bird flu at 618 days—but past COVID response shows potential for improvement
The global average for countries to report genetic information about bird flu, crucial to tracking and preventing a human pandemic, was seven months, and Canada came in last, a new study has found.
Cancer researchers identify the 'switch' that allows intestinal cells to regenerate after injury
Researchers from the University of Colorado Cancer Center have solved a cellular mystery that may lead to better therapies for colorectal and other types of cancer.
Neutrophils' mitochondrial sensing disrupted in lupus patients, study finds
Assistant Professor Andrew Monteith's lab in the Department of Microbiology is documenting how key immune cells detect infection and how that fails to happen in people with lupus.

FDA approves new drug to treat Alzheimer’s disease

Recent Posts

JUST IN